BOK Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40.6K | Hold |
490
| – | – | ﹤0.01% | 853 |
|
2025
Q1 | $39.7K | Sell |
490
-150
| -23% | -$12.2K | ﹤0.01% | 848 |
|
2024
Q4 | $57.2K | Sell |
640
-200
| -24% | -$17.9K | ﹤0.01% | 802 |
|
2024
Q3 | $81.2K | Sell |
840
-550
| -40% | -$53.2K | ﹤0.01% | 772 |
|
2024
Q2 | $129K | Buy |
1,390
+550
| +65% | +$51K | ﹤0.01% | 791 |
|
2024
Q1 | $78.8K | Buy |
840
+350
| +71% | +$32.8K | ﹤0.01% | 810 |
|
2023
Q4 | $43.8K | Hold |
490
| – | – | ﹤0.01% | 819 |
|
2023
Q3 | $32.5K | Hold |
490
| – | – | ﹤0.01% | 803 |
|
2023
Q2 | $40.8K | Sell |
490
-370
| -43% | -$30.8K | ﹤0.01% | 817 |
|
2023
Q1 | $65.5K | Buy |
+860
| New | +$65.5K | ﹤0.01% | 807 |
|
2017
Q4 | – | Sell |
-100
| Closed | -$9K | – | 1137 |
|
2017
Q3 | $9K | Buy |
+100
| New | +$9K | ﹤0.01% | 1092 |
|
2015
Q3 | – | Sell |
-2,685
| Closed | -$226K | – | 893 |
|
2015
Q2 | $226K | Hold |
2,685
| – | – | 0.01% | 778 |
|
2015
Q1 | $202K | Buy |
+2,685
| New | +$202K | 0.01% | 781 |
|